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The concept of ﬁbromyalgia has considerably evolved over
the past two decades and now incorporates symptoms
beyond pain, such as aﬀective disturbances and fatigue [1].
This evolution of the clinical understanding of ﬁbromyalgia,
together with neurophysiological research showing abnor-
malities in central pain processing, has helped to establish
the implication of the central nervous system (CNS) in
ﬁbromyalgia. The CNS, or more speciﬁcally the brain, is key
when the organism is not (or no longer) capable to mount
adaptive responses to stressors, that is, physical or emotional
stimuli that threaten homeostasis. As a consequence stress
turns into distress and homeostasis of the organism is no
longer maintained.
This special issue is centered on incorporating the
concept of (dis-)stress into our understanding of ﬁbromyal-
gia. A wide range of topics is covered, from clinical
presentation to pathophysiology to treatment approaches,
uniﬁed by the attempt to explore how stressors, together
with individual vulnerability, impact on ﬁbromyalgia. The
paper by M. A. Fitzcharles and M. B. Yunus explains
the clinical concept of ﬁbromyalgia, demonstrating what
ﬁbromyalgia is from a clinical standpoint and what it is
not. A call for standardization of assessment methods in
the diagnosis of ﬁbromyalgia and symptom severity as well
as treatment outcomes is made by C. S. Boomershine, who
provides a comprehensive evaluation of currently available
tools. This paper might well serve as a starting point
for discussions within groups like Outcome Measures in
Rheumatology (OMERACT) with the goal of providing
standardized assessment tools, which would clearly improve
comparison of study results. The contribution by M. B.
Yunus deals with the prevalence of ﬁbromyalgia in other
chronicpainconditions.Ononehand,theoverlapwithother
so-called functional pain syndromes is considered; on the
other hand, the prevalence of ﬁbromyalgia in diseases with
clear (structural) organic cause is discussed. This approach is
useful because it demonstrates that peripheral inﬂammatory
andnociceptiveeventsmaytriggerﬁbromyalgiasymptomsin
some patients while such events might be completely absent
in patients presenting without any other organic disease.
Then, Gracely et al. review commonalities and diﬀerences of
ﬁbromyalgia and depression. This is important for at least
two reasons. First, depression is a frequent comorbidity of
ﬁbromyalgia. Second, ﬁbromyalgia symptoms are regarded
by some clinicians and/or researchers as a manifestation of
a depressive disorder. The authors of this paper come to the
interestingconclusionthatalthough,ingeneral,ﬁbromyalgia
may be more appropriately grouped with other functional
pain disorders, certain subgroups of ﬁbromyalgia patients
with high level of psychological distress couldbe additionally
or solely grouped with aﬀective spectrum disorders.
The paper by L. A. Low and P. Schweinhardt investigates
how diﬀerent stressors early in life, including pain itself
as well as psychological trauma, contribute to increased
vulnerability of stress and pain systems to further insult later
in life. This is potentially important because it might explain
pathophysiological changes observed in adult ﬁbromyalgia
patients. The following four contributions are concerned2 Pain Research and Treatment
in detail with the pathophysiological alterations that might
underlie the numerous symptoms of ﬁbromyalgia. Ceko et
al. carefully describe the experimental evidence for altered
sensory processing that has been obtained in research set-
tings.Theauthorsdiscussincreasedsensitivity tonociceptive
stimulation, potentially altered endogenous pain modula-
tion as well as increased sensitivity in response to other
unpleasant sensory stimuli, which once more is indicative
of a CNS disturbance rather than peripheral tissue abnor-
malities. Accordingly, they discuss neurobiological changes
that might underlie ﬁbromyalgia symptoms. S. Becker and
P. Schweinhardt discuss in depth the possibility that dys-
functional neurotransmitter systems might be responsible
for ﬁbromyalgia symptoms. At ﬁrst glance, this notion might
seem at odds with the view that alterations in stress systems
underlieﬁbromyalgia.However,theauthorscarefullyexplain
howvarioussymptomsofﬁbromyalgiacouldbeexplainedby
dysfunctional neurotransmitter systems and how alterations
in the hypothalamic-pituitary-adrenal (HPA) stress system
ﬁt into this model. The paper by M. Martinez-Lavin is
concerned with the important role of the body’s second
stress system in ﬁbromyalgia. The paper illustrates how
dysregulation of the sympathetic nervous system could be
keyinconvertingdistressintopain.Lightetal.reviewgenetic
polymorphisms that have been implicated in conveying sus-
ceptibility for ﬁbromyalgia. In addition, they provide novel
and existing data showing diﬀerential alterations of gene
expression proﬁles in ﬁbromyalgia and ﬁbromyalgia comor-
bid with chronic fatigue syndrome. These results empha-
size the importance of carefully subgrouping ﬁbromyalgia
patients. Furthermore, the genes identiﬁed include genes
pertaining to the adrenergic system, to exercise-responsive
metabolite sensing ion channels, and to sensory receptors
possibly responding to muscle fatigue. Thereby they provide
further evidence how autonomic dysregulation and vaso-
constriction could be turned into ischemic muscle pain and
fatigue.
Treatment for ﬁbromyalgia presently consists of a mul-
timodal approach combining pharmacological and non-
pharmacological interventions. Two papers in this special
issue directly address the important topic of treatment,
incorporating current information on pathophysiology in
the choice of treatment. The ﬁrst one by C. J. Vierck is
built on the hypothesis that pain in ﬁbromyalgia might be
partly caused by insuﬃcient perfusion of skeletal muscles, as
mentioned in the preceding paragraph. The author focuses
on physical exercise as a ﬁrst-line treatment for ﬁbromyalgia
withtherationalethatexercisecanattenuateconsequencesof
stress in the periphery, that is, vasoconstriction and resulting
ischemic pain, as well as in the CNS. In the CNS, exercise
could interrupt the reciprocal interactions between stress
and systems that control autonomic regulation, mood, sleep,
and possibly pain sensitivity. The paper by R. L. Woolfolk
et al. in the special issue addresses a therapeutic interven-
tion that directly targets the CNS. They report on using
an individually administered form of cognitive behavioral
therapy(CBT)withanemphasisonachievingcompetencein
relaxation methods and improving patients’ emotional self-
awareness. The results of this form of CBT are impressive—
almost two thirds of patients in the treatment group show
30% pain reduction compared to 5% in the control group
that received treatment as usual. This is an encouraging start
and justiﬁes future studies focusing on determining which
aspect of the individualized aﬀective CBT drove those good
treatmentresultsbyusingmoresophisticatedcontrolgroups.
The reader will appreciate some divergence between the
diﬀerent contributions to this special issue. For example,
central sensitization has been classically regarded as a spinal
process resulting from prolonged and/or high intensity aﬀer-
ent barrage related to peripheral injury. Then, some authors
started to use the term relatively loosely by using it for
any suspected CNS ampliﬁcation of nociceptive processing.
Recently, psychological stress has been shown to indeed
modulate spinal glutamatergic neurotransmission, albeit
possibly with diﬀerent mechanisms than classical central
sensitization [2]. These examples indicate that disturbance
of homeostasis by diﬀerent types of stressors, such as
peripheral injury or psychological stress, might result in
pain augmentation via diﬀerent mechanisms. It remains to
be determined whether there is a ﬁnal common pathway
of how diﬀerent types of stressors that exceed the adaptive
capacity of an individual lead to ﬁbromyalgia. Although
many questions regarding ﬁbromyalgia are still unsolved, we
have already come a long way. New diagnostic criteria have
been developed and new etiological frameworks incorpo-
rating vulnerability to stress have been proposed. Research
has greatly advanced our understanding of physiological
alterations associated with ﬁbromyalgia, including changes
of the autonomic system and the CNS. Finally, nonpharma-
cologicaltreatmentapproacheshavebeensuggestedbasedon
the improved understanding of this challenging condition.
Advancing our understanding of the mechanisms responsi-
ble for converting distress into pain and other symptoms of
ﬁbromyalgia further will likely have important implications
for the development of new therapeutic perspectives.
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